Literature DB >> 9841380

Shutting down a gene. Antisense drug wins approval.

G Stix.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9841380     DOI: 10.1038/scientificamerican1198-46b

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  5 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

Review 2.  Crystallographic studies of chemically modified nucleic acids: a backward glance.

Authors:  Martin Egli; Pradeep S Pallan
Journal:  Chem Biodivers       Date:  2010-01       Impact factor: 2.408

3.  Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides.

Authors:  María González Ferreiro; Lloyd G Tillman; Gregory Hardee; Roland Bodmeier
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

4.  Modified Oligonucleotides: New Structures, New Properties, and New Spheres of Application.

Authors:  V G Metelev; T S Oretskaya
Journal:  Russ J Bioorg Chem       Date:  2021-04-26       Impact factor: 0.796

Review 5.  Opportunities and challenges for antisense oligonucleotide therapies.

Authors:  Elsa C Kuijper; Atze J Bergsma; W W M Pim Pijnappel; Annemieke Aartsma-Rus
Journal:  J Inherit Metab Dis       Date:  2020-06-03       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.